Lemborexant Synthesis Route for Low-Impurity Industrial Production
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing Lemborexant, a potent orexin receptor antagonist, face challenges such as low yield, the need to account for residual enzymes in industrial production, and the presence of significant impurities like compounds of Formula VI, Formula IX, Formula X, Formula XII, Formula XIV, and Formula XV.
Innovation Solution
A synthesis method involving specific chemical reactions and purifications, including the use of Grignard reagents, oxidants like sodium hypochlorite and sodium chlorite, and controlled temperature and solvent conditions, to produce Lemborexant with reduced impurities, achieving high purity through high-performance liquid chromatography (HPLC) analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the production method from Patent Literature 1 is used (synthesizing Lemborexant from compound Prep 14-2 through compound Prep 14-3), then the synthesis pathway is established, but the yield is low
Solution Approach 1:
The patent optimizes reaction parameters including temperature, solvent composition (toluene/tetrahydrofuran ratio), and addition rates to improve yield. Specifically, controlling the reaction temperature and using a mixed solvent system enhances the efficiency of the Grignard reaction and subsequent steps, resolving the low yield issue while maintaining manufacturability
Solution Approach 2:
The patent replaces enzyme-based chemical reactions with Grignard reagent-based chemical reactions. This substitution eliminates the need to account for residual enzymes in industrial production facilities, improving ease of manufacture while achieving high yield through optimized chemical reaction conditions
2Manufacturing precision
If the production method from Patent Literature 2 is used (synthesizing Lemborexant from compound 5 through compound 6 by acetylation with enzyme), then the reaction specificity is improved, but residual enzymes must be accounted for in industrial production
Solution Approach 1:
The patent replaces enzyme-catalyzed acetylation with Grignard reagent-based chemical reactions followed by standard workup procedures. This substitution eliminates biological contaminants from the process, removing the need for special facility cleaning protocols while maintaining reaction efficiency and precision through controlled chemical conditions
3Ease of manufacture
If conventional production methods are used, then the synthesis process is established, but compounds of Formula VI, Formula IX, Formula X, Formula XII, Formula XIV and Formula XV are contained as impurities
Solution Approach 1:
The patent employs systematic purification steps including filtration, washing, and chromatography to remove impurities (compounds of Formula VI, IX, X, XII, XIV, and XV) from the reaction mixture. These extraction and separation operations isolate the desired Lemborexant product while removing side products and unreacted materials, achieving high purity (>98%) while maintaining an established synthesis process
Solution Approach 2:
The patent uses intermediate compounds and protecting groups strategically to prevent formation of certain impurities during synthesis. By controlling the sequence of reactions and using appropriate intermediates, the method minimizes side reactions that would generate impurities, thereby improving manufacturing precision without complicating the overall process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method enables the production of Lemborexant with a content of impurities below 1.0 mass % and a yield improvement, suitable for industrial applications as an orexin-2 receptor antagonist.
Implementation Method 1
adding a Grignard reagent to a mixture comprising a compound of Formula II: toluene and tetrahydrofuran
Implementation Method 2
allowing a compound of Formula VII: to react with an oxidant. In one embodiment, the step of allowing the compound of Formula VII to react with the oxidant is performed by sequentially adding sodium hypochlorite and sodium chlorite as the oxidant
Implementation Method 3
achieving high purity through high-performance liquid chromatography (HPLC) analysis
Data Source
AI summary
The present application discloses a method and a compound that are useful for preparation of a compound of Formula (XI). Furthermore, the present application discloses the compound of Formula (XI) comprising a small amount of impurities.